CONSUN PHARMA(01681)

14.130+0.340+2.47%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- China's Gushengtang Holdings HY Revenue Rises on Offline Medical Institution Expansion
  Reuters · 08-28 12:25
  China's Gushengtang Holdings HY Revenue Rises on Offline Medical Institution Expansion
- HK Stock Market Highlights: Butong Group's Interim Profit Soars 98.28%, Plans AI Enhancements for Core Products
  Stock News · 08-27
  HK Stock Market Highlights: Butong Group's Interim Profit Soars 98.28%, Plans AI Enhancements for Core Products
- China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%
  Reuters · 08-26
  China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%
- Consun Pharma FY26 H1 Profit Attributable to Shareholders Rises 19.5% to RMB 595.31 Million; Revenue Increases 13.8% to RMB 1.78 Billion
  Reuters · 08-26
  Consun Pharma FY26 H1 Profit Attributable to Shareholders Rises 19.5% to RMB 595.31 Million; Revenue Increases 13.8% to RMB 1.78 Billion
- Consun Pharmaceutical Declares Interim Dividend of HKD 0.38 Per Share
  Reuters · 08-26
  Consun Pharmaceutical Declares Interim Dividend of HKD 0.38 Per Share
- Singapore's Thomson Medical Group FY Revenue Rises on Singapore Strength, Malaysia Oncology Contribution
  Reuters · 08-26
  Singapore's Thomson Medical Group FY Revenue Rises on Singapore Strength, Malaysia Oncology Contribution
- CONSUN PHARMA Sets October Date for Interim Dividend Payout
  Stock News · 08-26
  CONSUN PHARMA Sets October Date for Interim Dividend Payout
- CONSUN PHARMA Posts 19.5% Profit Growth in First-Half Results, Renal Product Line Up 18.1%
  Stock News · 08-26
  CONSUN PHARMA Posts 19.5% Profit Growth in First-Half Results, Renal Product Line Up 18.1%
- Earning Preview: CONSUN PHARMA this quarter’s revenue is expected to increase by 0%, and institutional views are bullish
  Earnings Agent · 08-19
  Earning Preview: CONSUN PHARMA this quarter’s revenue is expected to increase by 0%, and institutional views are bullish
- CONSUN PHARMA: FIDELITY INVESTMENT TRUST Acquires Shares, Long Position Rises to 5.0%
  HK Disclosure · 08-18
  CONSUN PHARMA: FIDELITY INVESTMENT TRUST Acquires Shares, Long Position Rises to 5.0%
- Consun Pharmaceutical schedules 26 Aug 2026 board meeting to approve interim results and dividend proposal
  Bulletin Express · 08-10
  Consun Pharmaceutical schedules 26 Aug 2026 board meeting to approve interim results and dividend proposal
- Consun Pharmaceutical Sets Board Meeting to Review Interim Results
  Reuters · 08-10
  Consun Pharmaceutical Sets Board Meeting to Review Interim Results
- Consun Pharma Reports No Share Capital Changes in July 2026 Monthly Return
  Bulletin Express · 08-04
  Consun Pharma Reports No Share Capital Changes in July 2026 Monthly Return
- Undiscovered Gems In Asia To Watch This July 2026
  Simply Wall St. · 07-03
  Undiscovered Gems In Asia To Watch This July 2026
- CONSUN PHARMA Spends HK$792,000 on Share Buyback
  Stock News · 06-30
  CONSUN PHARMA Spends HK$792,000 on Share Buyback
- Consun Pharma Files HKEX Next-day Disclosure Return Reporting Share Buyback
  Reuters · 06-30
  Consun Pharma Files HKEX Next-day Disclosure Return Reporting Share Buyback
- CONSUN PHARMA Executes Share Buyback Worth HK$1.96 Million
  Stock News · 06-26
  CONSUN PHARMA Executes Share Buyback Worth HK$1.96 Million
- Consun Pharma Files HKEX Next-day Disclosure Return After Share Buyback at HKD 12.83
  Reuters · 06-26
  Consun Pharma Files HKEX Next-day Disclosure Return After Share Buyback at HKD 12.83
- Consun Pharma repurchases 90,000 shares; treasury stock rises to 2.28 million
  Bulletin Express · 06-25
  Consun Pharma repurchases 90,000 shares; treasury stock rises to 2.28 million
- CONSUN PHARMA Executes Share Buyback, Spending HK$378,900
  Stock News · 06-24
  CONSUN PHARMA Executes Share Buyback, Spending HK$378,900
Company Profile
Company Name
CONSUN PHARMA
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.chinaconsun.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
- 08-26
  Interim Report
  INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2026
  INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2026
- 04-28
  Annual Report
  ANNUAL REPORT 2025
  ANNUAL REPORT 2025

1D
5D
Day
Week
Month

Loading ...

High

14.300

Open

14.070

Volume%

0.73

Low

13.750

13.790

T/O Rate

0.34%

To The Moon

CONSUN PHARMA(01681)

Company Profile

Most Discussed